Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126824761 | 12682476 | 1 | I | 20160822 | 20160825 | 20160825 | EXP | SK-ROCHE-1818729 | ROCHE | 0.00 | A | F | Y | 0.00000 | 20160825 | MD | SK | SK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126824761 | 12682476 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Unknown | U | UNKNOWN | 103705 | |||||||||
| 126824761 | 12682476 | 2 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNKNOWN | 0 | |||||||||||
| 126824761 | 12682476 | 3 | C | DOXORUBICIN | DOXORUBICIN | 1 | UNKNOWN | 0 | |||||||||||
| 126824761 | 12682476 | 4 | C | VINCRISTIN | VINCRISTINE | 1 | UNKNOWN | 0 | |||||||||||
| 126824761 | 12682476 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126824761 | 12682476 | 1 | B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126824761 | 12682476 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126824761 | 12682476 | Abdominal pain | |
| 126824761 | 12682476 | Ascites | |
| 126824761 | 12682476 | Decreased appetite | |
| 126824761 | 12682476 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |